Mianen Sun, Ph.D.
Affiliations: | 2008 | Cell Biology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Cell BiologyGoogle:
"Mianen Sun"Parents
Sign in to add mentor| Richard S. Jope | grad student | 2008 | UAB | |
| (The role of DDX3 in regulating apoptosis, p53 and Snail.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jonasch E, Sun M, Tong P, et al. (2017) HNF1B loss exacerbates the development of chromophobe renal cell carcinomas. Cancer Research |
| Jonasch E, Hoang A, Sun M, et al. (2016) Sunitinib to upregulate IFNg-STAT1 signaling and to increase indoleamine 2,3-dioxygenase (IDO) expression in renal cell carcinoma (RCC). Journal of Clinical Oncology. 34: 614-614 |
| Liu X, Hoang A, Sun M, et al. (2016) Abstract A147: Sunitinib upregulates IFNγ-STAT1 signaling to modulate the tumor immune microenvironment in renal cell carcinoma Cancer Immunology Research. 4 |
| Zhou L, Liu XD, Sun M, et al. (2015) Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene |
| Liu X, Hoang A, Zhou L, et al. (2015) Resistance to anti-angiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma. Cancer Immunology Research |
| Liu XD, Yao J, Tripathi DN, et al. (2015) Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis. Oncogene. 34: 2450-60 |
| Liu X, Hoang A, Zhou L, et al. (2015) Association of resistance to antiangiogenic therapy with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma. Journal of Clinical Oncology. 33: 419-419 |
| Ding Z, German P, Bai S, et al. (2014) Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein. Cancer Research. 74: 3127-36 |
| Zhang D, Wang H, Sun M, et al. (2014) Speckle-type POZ protein, SPOP, is involved in the DNA damage response. Carcinogenesis. 35: 1691-7 |
| Zhou L, Liu X, Sun M, et al. (2014) Abstract 687: The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma Cancer Research. 74: 687-687 |